CN103239707A - Eye drop for treating myopia - Google Patents
Eye drop for treating myopia Download PDFInfo
- Publication number
- CN103239707A CN103239707A CN2013101918853A CN201310191885A CN103239707A CN 103239707 A CN103239707 A CN 103239707A CN 2013101918853 A CN2013101918853 A CN 2013101918853A CN 201310191885 A CN201310191885 A CN 201310191885A CN 103239707 A CN103239707 A CN 103239707A
- Authority
- CN
- China
- Prior art keywords
- parts
- eye drop
- myopia
- silver ion
- flos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an eye drop for treating myopia. The eye drop comprises the following components in parts by weight: 4-7 parts of flos chrysanthemi indici, 3.5-3.9 parts of honeysuckle, 9-10 parts of cuscuta chinensis, 3-3.9 parts of oleum menthae, 6-9.8 parts of silver ion solution, and 4-8.9 parts of mulberry silk fiber. The eye drop can alleviate asthenopia.
Description
Technical field
The present invention relates to a kind of eye drop, be specifically related to a kind of eye drop for the treatment of myopia.
Background technology
Existing eye drop is remitting vision fatigue, and does not have therapeuticing and health effect.
Summary of the invention
Goal of the invention: the present invention provides a kind of eye drop for the treatment of myopia in order to solve the deficiencies in the prior art.
Technical scheme: a kind of eye drop for the treatment of myopia, formed by following each compositions in weight portion: Flos Chrysanthemi Indici 4-7 part, Flos Lonicerae 3.5-3.9 part, Semen Cuscutae 9-10 part, Oleum menthae 3-3.9 part, silver ion solution 6-9.8 part, mulberry silk fiber 4-8.9 part.
As preferably, described eye drop is made up of following each compositions in weight portion: 5 parts of Flos Chrysanthemi Indicis, 3.7 parts of Flos Loniceraes, 9.5 parts of Semen Cuscutae, 3.5 parts of Oleum menthae, 7.3 parts of silver ion solutions, 6 parts of mulberry silk fibers.
Beneficial effect: the present invention compares with existing technology, can alleviate myopia.
The specific embodiment
The present invention will be described in detail below in conjunction with specific embodiment.
Specific embodiment:
Embodiment 1:
A kind of eye drop for the treatment of myopia is made up of following each compositions in weight portion: 4 parts of Flos Chrysanthemi Indicis, Flos Lonicerae 3.5-part, 9 parts of Semen Cuscutae, 3 parts of Oleum menthae, 6 parts of silver ion solutions, 4 parts of mulberry silk fibers.
Embodiment 2:
A kind of eye drop for the treatment of myopia is made up of following each compositions in weight portion: 5 parts of Flos Chrysanthemi Indicis, 3.7 parts of Flos Loniceraes, 9.5 parts of Semen Cuscutae, 3.5 parts of Oleum menthae, 7.3 parts of silver ion solutions, 6 parts of mulberry silk fibers.
Embodiment 3:
A kind of eye drop for the treatment of myopia is made up of following each compositions in weight portion: 7 parts of Flos Chrysanthemi Indicis, 3.9 parts of Flos Loniceraes, 10 parts of Semen Cuscutae, 3.9 parts of Oleum menthae, 9.8 parts of silver ion solutions, 8.9 parts of mulberry silk fibers.
Claims (2)
1. treat near-sighted eye drop for one kind, it is characterized in that: described eye drop is made up of following each compositions in weight portion: Flos Chrysanthemi Indici 4-7 part, Flos Lonicerae 3.5-3.9 part, Semen Cuscutae 9-10 part, Oleum menthae 3-3.9 part, silver ion solution 6-9.8 part, mulberry silk fiber 4-8.9 part.
2. the eye drop for the treatment of myopia as claimed in claim 1, it is characterized in that: described eye drop is made up of following each compositions in weight portion: 5 parts of Flos Chrysanthemi Indicis, 3.7 parts of Flos Loniceraes, 9.5 parts of Semen Cuscutae, 3.5 parts of Oleum menthae, 7.3 parts of silver ion solutions, 6 parts of mulberry silk fibers.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101918853A CN103239707A (en) | 2013-05-22 | 2013-05-22 | Eye drop for treating myopia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101918853A CN103239707A (en) | 2013-05-22 | 2013-05-22 | Eye drop for treating myopia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103239707A true CN103239707A (en) | 2013-08-14 |
Family
ID=48919810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101918853A Pending CN103239707A (en) | 2013-05-22 | 2013-05-22 | Eye drop for treating myopia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103239707A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9394355B2 (en) | 2014-08-20 | 2016-07-19 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
CN111097036A (en) * | 2019-05-05 | 2020-05-05 | 刘祝成 | Eye care compositions, products and methods of use thereof |
US10953132B2 (en) | 2016-04-08 | 2021-03-23 | Cornell University | Method to enhance wound healing using silk-derived protein |
US11242367B2 (en) | 2016-08-12 | 2022-02-08 | Silk Technologies, Ltd. | Silk-derived protein for treating inflammation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1650998A (en) * | 2002-06-03 | 2005-08-10 | 宋志民 | Preparation method of Chinese medicinal eye drops for treating myopia |
CN101642505A (en) * | 2008-08-04 | 2010-02-10 | 刘燕超 | Eye drop for treating myopic eyes |
-
2013
- 2013-05-22 CN CN2013101918853A patent/CN103239707A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1650998A (en) * | 2002-06-03 | 2005-08-10 | 宋志民 | Preparation method of Chinese medicinal eye drops for treating myopia |
CN101642505A (en) * | 2008-08-04 | 2010-02-10 | 刘燕超 | Eye drop for treating myopic eyes |
Non-Patent Citations (2)
Title |
---|
冯贵林等: ""近视眼的中药治疗"", 《中华实用医药杂志》, vol. 5, no. 16, 31 August 2005 (2005-08-31) * |
戎曙欣等: ""李清文教授从肝论治眼病的经验"", 《河北中医》, vol. 29, no. 1, 31 January 2007 (2007-01-31) * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9394355B2 (en) | 2014-08-20 | 2016-07-19 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
US9907836B2 (en) | 2014-08-20 | 2018-03-06 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
US10471128B2 (en) | 2014-08-20 | 2019-11-12 | Silk Technologies, Ltd. | Fibroin-derive protein composition |
US11045524B2 (en) | 2014-08-20 | 2021-06-29 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
US11890328B2 (en) | 2014-08-20 | 2024-02-06 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
US10953132B2 (en) | 2016-04-08 | 2021-03-23 | Cornell University | Method to enhance wound healing using silk-derived protein |
US11242367B2 (en) | 2016-08-12 | 2022-02-08 | Silk Technologies, Ltd. | Silk-derived protein for treating inflammation |
CN111097036A (en) * | 2019-05-05 | 2020-05-05 | 刘祝成 | Eye care compositions, products and methods of use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015501703A1 (en) | Trifluormethyl-substituted ring-fused pyrimidines and use thereof | |
CN103239707A (en) | Eye drop for treating myopia | |
TN2014000298A1 (en) | Substituted annulated pyrimidines and triazines, and use thereof | |
PE20150223A1 (en) | ANTIBODIES ENHANCED ANTIBODIES AGAINST GROWTH AND DIFFERENTIATION FACTOR-8 AND THE USES OF THEM | |
JO3199B1 (en) | Substituted 5-fluoro-1H-pyrazolopyridines and their use | |
AR096114A1 (en) | ELIMINATION OF SODIUM SULPHATE FROM WASTEWATER TREATED BIOLOGICALLY | |
AR088866A1 (en) | DEVICE AND METHOD FOR WATER TREATMENT | |
PH12016500608A1 (en) | Cyclic thienouracil-carboxamides and use thereof | |
WO2013181446A3 (en) | Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of n-acetyl-aspartic acid | |
EP2596787A4 (en) | New use of hesperetin | |
AR090804A1 (en) | PROCEDURE FOR THE RECOVERY OF AROMA OF TE | |
BR112014029308A2 (en) | a method of improving liver function | |
CN104288813A (en) | Air freshener | |
CN103741335A (en) | Aromatic anti-radiation fabric | |
CN204211577U (en) | A kind of week-base water machine | |
CN102400392A (en) | Natural silk fabric refining liquid | |
UA50454U (en) | Method for treating and prophylaxis of bee varroosis | |
CN203025426U (en) | Glasses | |
CN109984625A (en) | A kind of pollution-free descalling technique | |
CN203282936U (en) | Jade bottle | |
CN102398967A (en) | Food processing wastewater treatment agent | |
CN103798174A (en) | Fish tank structure | |
CN102846530A (en) | Novel herbal bath salt | |
CN104013645A (en) | Prescription for treating deuteropathic deafness | |
TONG | Human Rights Progress As a Matter of Fact |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130814 |